D000806Chemicals & DrugsD27.505.519.389.745.085501560.915188Angiotensin-Converting Enzyme InhibitorsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonWake Forest School of MedicineCarlosFerrarioCarlos M. Ferrario MD36.09032400000000-80.26649100000000132Ferrario, CarlosProfessor EmeritusDebraDizDebra I. Diz PhD36.09032400000000-80.26649100000000200Diz, DebraProfessorDalaneKitzmanDalane W. Kitzman MD36.09003100000000-80.26802800000000228Kitzman, DalaneProfessorMarkChappellMark C. Chappell PhD36.09032400000000-80.26649100000000616Chappell, MarkProfessorAndrewSouthAndrew M. South MD, MS36.08959100000000-80.268599000000001822South, AndrewAssociate Professor31070702Brown JD, Smith SM, Strotmeyer ES, Kritchevsky SB, Gill TM, Blair SN, Fielding RA, Buford TW, Pahor M, Manini TMThe journals of gerontology. Series A, Biological sciences and medical sciencesBrown JD, Smith SM, Strotmeyer ES, Kritchevsky SB, Gill TM, Blair SN, Fielding RA, Buford TW, Pahor M, Manini TM. Comparative Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Response to a Physical Activity Intervention in Older Adults: Results From the Lifestyle Interventions and Independence for Elders Study. J Gerontol A Biol Sci Med Sci. 2020 04 17; 75(5):1010-1016.J Gerontol A Biol Sci Med Sci2020-04-17T00:00:002020Comparative Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Response to a Physical Activity Intervention in Older Adults: Results From the Lifestyle Interventions and Independence for Elders Study.24Assistant Professor32220930Sparks MA, South A, Welling P, Luther JM, Cohen J, Byrd JB, Burrell LM, Batlle D, Tomlinson L, Bhalla V, Rheault MN, Soler MJ, Swaminathan S, Hiremath SClinical journal of the American Society of Nephrology : CJASNSparks MA, South A, Welling P, Luther JM, Cohen J, Byrd JB, Burrell LM, Batlle D, Tomlinson L, Bhalla V, Rheault MN, Soler MJ, Swaminathan S, Hiremath S. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19. Clin J Am Soc Nephrol. 2020 May 07; 15(5):714-716.Clin J Am Soc Nephrol2020-03-27T00:00:002020Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19.32367746South AM, Brady TM, Flynn JTHypertension (Dallas, Tex. : 1979)South AM, Brady TM, Flynn JT. ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective. Hypertension. 2020 07; 76(1):16-22.Hypertension2020-05-05T00:00:002020ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective.32496917Cohen JB, Hanff TC, South AM, Sparks MA, Hiremath S, Bress AP, Byrd JB, Chirinos JACirculation researchCohen JB, Hanff TC, South AM, Sparks MA, Hiremath S, Bress AP, Byrd JB, Chirinos JA. Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19". Circ Res. 2020 06 05; 126(12):e140-e141.Circ Res2020-06-04T00:00:002020Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19".33186321Cohen JB, D'Agostino McGowan L, Jensen ET, Rigdon J, South AMJournal of hypertensionCohen JB, D'Agostino McGowan L, Jensen ET, Rigdon J, South AM. Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding. J Hypertens. 2021 04 01; 39(4):795-805.J Hypertens2021-04-01T00:00:002021Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding.Internal Medicine, Cardiovascular MedicinePediatrics, NephrologySurgery, GeneralSurgery, Hypertensiontrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Professor EmeritusProfessor Emeritustrue1ProfessorProfessortrue1ProfessorProfessor3.84960.012311350research area of0.8171610.0454983127subject area for